Recombinant adenoviruses containing the canine factor IX (FIX) cDNA were directly introduced in the hind leg muscle of mice. We show that (i) in nude mice, high expression (1-5 ,ug/ml in plasma) of FIX protein can be detected for >300 days; (ii) in contrast, expression of FIX protein was transient (7-10 days) in normal mice; (iii) CD8+ lymphocytes could be detected within 3 days in the infected muscle tissue; (iv) use of i32-microglobulin and immunoglobulin M heavy chain "knockout" mice showed that lack of sustained expression of FIX protein is due to cell-mediated and humoral immune responses; (v) normal mice, once infected with recombinant adenovirus, could not be reinfected efficiently for at least 30 days due to neutralizing viral antibodies; and, finally, (vi) using immunosuppressive drugs, some normal mice can be tolerized to produce and secrete FLIX protein for >5 months. We conclude that currently available adenoviral vectors have serious limitations for use for longterm gene therapy.
Gene therapy holds a great promise for the treatment of many genetic diseases. Retroviral vectors have been extensively used to deliver genes into a wide variety of cell types but require ex vivo approaches because of their inability to infect postmitotic cells. In recent years much attention has been focused on a vector system that can deliver genes with high efficiency to a wide spectrum of nondividing cells in vivo. In particular, re- combinant adenoviruses have been demonstrated to be very useful (1) (2) (3) (4) (5) . Unfortunately, several studies with different gene products have revealed that following infection in a wide variety of target tissues, only transient expression is observed (6) (7) (8) (9) (10) (11) (12) . Since the cells infected with the recombinant adenoviruses are rapidly eliminated, it is likely that the host immune system plays a major role in preventing sustained expression of the foreign genes. We have therefore undertaken a characterization of the specific immune responses and antigens involved in the lack of sustained expression by adenoviral factor IX (FIX) mediated gene therapy.
MATERIALS AND METHODS
Adenoviral Vectors. The canine FIX adenoviral vector AdMCdF9 was prepared as follows: a 2.5-kb fragment containing mouse muscle creatine kinase enhancer, cytomegalovirus enhancer/promoter, and dog FIX cDNA was excised from the retroviral vector LNMECIXL (13) and inserted into adenoviral plasmid pXCJL1 together with a 170-bp simian virus 40 poly(A) sequence. AdMCLacZ is identical to AdMCdF9 except that the canine FIX cDNA was replaced with Escherichia coli 13-galactosidase (lacZ) gene. Both FIX 
and lacZ constructs
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in pXCJL1 were cotransfected with the pJM17 plasmid (14) into 293 cells (15), respectively, and recombinant adenoviral plaques were isolated and further purified by two rounds of plaque assays as described (16). The adenoviral vectors were propagated in 293 cells and purified by double CsCl banding as described (16). The purified virus was dialyzed against phosphate-buffered saline (PBS) and stored in aliquots with 15% glycerol at -80°C.
Animal Procedures. Adult Swiss Webster mice and nude (nu/nu) athymic mice were purchased from Harlan-SpragueDawley. 132-Microglobulin knockout, 132m(-/-), mice (17) and IgM heavy chain (,t chain) knockout, ,uMT/,uMT mice (18) were kindly provided by Leonard Shultz (The Jackson Laboratory). About 1 x 109 plaque-forming units (pfu) of purified AdMCdF9 or AdMCLacZ virus was diluted into 100 ,ul of PBS and injected into muscles of both hind legs of anesthetized adult mice at 6-10 weeks of age (5-10 ,ul per site, 50 ,ul per leg). Plasma was taken by bleeding the tail vein at the indicated times and canine FIX in mouse plasma was determined by ELISA (19). For immunosuppression, 50 mg of cyclophosphamide (CyP) per kg (Adria Laboratories) and 10 mg of cyclosporine A (CsA) per kg (Sandoz Pharmaceutical) were given i.p. three times every 2 weeks for 8 weeks.
Histology and Immunocytochemistry. Muscles from hind legs of injected mice were used in morphology and immunolabeling studies. For morphological observation, the muscle was fixed in Bouin's fixative overnight, embedded in paraffin, sectioned, and stained in hematoxylin/eosin. For Immunity. Therapeutic levels of FIX (5 ,ug/ml) in mouse plasma could be detected following infection with 109 pfu of recombinant virus in the muscle tissue of nude mice, which gradually declined to 1 ,ug/ml over a period of 1 year (Fig. 1A) .
Even though adenoviral DNA does not integrate in the host chromosome, the slow "turnover" of muscle cells allows the sustained expression for extended periods. However, when the same FIX adenoviruses were injected in normal mice, expression of FIX (ranging from 0.1 to 1 ,ug/ml) declined precipitously within days to basal level (Fig. 1B) . Because canine FIX expressed in mice is antigenic, the lack of FIX expression may be due to the presence of FIX Ab in the mouse plasma (20) . Indeed, FIX Ab can be detected by day 13 (see Fig. 4A4 ). To further investigate the possibility that production of FIX Ab may be responsible for the lack of measurable FIX protein in the plasma, we infected the recombinant viruses in ,uMT/,uMT mice. Once again, expression of FIX protein declined (Fig. 1C ) even though no FIX Ab were detectable (see Fig. 4C ). We presumed that the loss of FIX expression could, in addition, be due to cytotoxic T lymphocyte (CTL) response against the viral antigens and, perhaps, FIX protein. We therefore injected recombinant adenoviruses into f32m(-/-) mice (Fig.   1D ). Expression of FIX protein declined rapidly, perhaps due to Ab to FIX protein ( Fig. 1D; see Fig. 4C ). From these results we conclude that recombinant adenoviral vectors introduced in mouse muscle elicit cellular and humoral immune response.
To confirm the cellular immune response to recombinant adenoviruses, we performed histology on the infected tissues. Fig. 2 shows migration of lymphocytes in muscle within 24 hr of infection (Fig. 2B) . The presence of CD8+ cells was confirmed by staining with CD8-specific Ab (Fig. 2E) . Infiltration of lymphocytes could be detected in tkMT/1LMT (Fig. 2F) but not in 132m(-/-) mice (Fig. 2G) . Thus, it appears that rapid cellular immune response may lead to elimination of infected muscle cells leading to loss of FIX expression. The presence of CD8+ lymphocytes and dependence on 932m suggested that the CTL responses are major histocompatibility complex class I restricted, which requires de novo protein synthesis. The use of ElA defective adenoviruses to construct AdMCdF9 implied lack of viral replication, but at high multiplicity of infection the requirement for ElA can be overcome by some cellular factor (21) . We therefore tested to see if mRNAs for late viral proteins are synthesized in infected cells, and data obtained with reverse transcription-polymerase chain reaction (RT-PCR) in Fig.   3 shows that mRNA for hexon is detectable in muscle cells 4 days after infection.
To confirm that Ab against adenoviral proteins are generated, we performed Western blot analysis on the serum obtained from infected mice. Fig. 4A shows that FIX Ab can be detected in mice at day 13 following infection and levels remain high thereafter for at least 43 days. No FIX Ab were detectable in ,uMT/,tMT mice (Fig. 4C) but could be readily detected in 632m(-/-) mice (Fig.  4C) . In addition to the Ab to canine FIX, extensive humoral responses to adenoviral antigens were also detected in infected animals. Specifically, Ab against viral hexon and fiber protein could be readily detected (Fig. 4B) .
Reinfection with Recombinant Adenoviruses. Since adenoviruses do not integrate, it is important to know if the animals can be reinfected, once the expression levels diminish. However, the presence of the host immune response in the infected animals suggests that reinfection may not be productive or efficient. We therefore reinfected mice that were previously infected for 30 days with either recombinant FIX adenovirus or with recombinant lacZ-,B-gal adenovirus. Results in Fig. 5 show that 1 day after reinfection in Swiss Webster mice, vector (lacZ adenovirus) primed animals express <20% of factor IX produced in the naive mice, while animals primed with FIX adenovirus barely express detectable amounts of FIX. When similar experiments were carried out in ,MT/,uMT mice incapable of generating Ab, about 60% of the activity could be detected when the animals were primed with lacZ adenovirus. We infer from these results that the loss of activity is due to CTL response to viral antigens. These data are predicted by the extensive lymphocyte infiltration in the muscle of adenovirus (Fig. 2 B-E), (ii) lack of lymphocyte infiltration in 12m(-/-) mice (Fig. 2F) cells as judged by RT-PCR analysis (Fig. 3) . Recent results by Engelhardt etal. (24) , where a temperature-sensitive E2A gene was used to construct recombinant adenovirus, suggests that CTL response to viral antigens can be reduced at nonpermissive temperature. Thus it is hopeful that a second generation of adenoviral vectors where ElA, E2A, and perhaps E4 gene have been deleted or rendered ineffective will be able to reduce the CMI problem. There appears to be a general consensus that the E3 region, known to prevent viral antigen presentation by major histocompatibility complexes I and II, is useful to retain in the viral vectors as it prevents CTL killing of target cells.
The problem of humoral response to viral antigens presents two major obstacles: (i) inability to reinfect with recombinant adenoviruses and (ii) a sizeable population is seropositive and may be resistant to infection. Reinfection of ,uMT/,MT mice shows that in the absence of humoral response, >60% levels of FIX protein can be detected. The lack of full expression is likely due to the presence of CTLs (Fig. 2H) . Although we have not tried to reinfect nude mice, it is likely that reinfection will be possible. The long-term expression in the nude mice as compared to 32m(-/-) ( Fig.   1 ) is because the athymic mice, in addition to lacking CD8+ lymphocytes, also lack CD4+ lymphocytes. Since B-cell development and antibody diversity require CD4+ helper T cells, the possibility of generating effective neutralizing Ab in nude mice is unlikely. Therefore the data from nude mice represent the in vivo expression in a CTL and antibody-free environment.
The fact that long-term expression of secreted antigens (this study) and nonsecreted antigens (23) in nude mice is possible raises interest in tolerizing the host. Neonatal injections have been widely used to tolerize experimental animals and recently have been successfully used to allow long-term expression from recombinant adenoviruses (25) . However, neonatal injections have never been reported in humans, and it is unlikely that this will be an approved practice for human gene therapy. Therefore, we explored the effectiveness of widely used immunosuppressive drugs (22) . CsA had no effect on FIX expression, a result anticipated since CsA is not a potent inhibitor of humoral immunity. The increase in FIX expression in animals treated with CyP is most likely due to this drug's ability to eliminate CMI and humoral response. Although only one in four mice was completely tolerant, this demonstrates that adult animals can be tolerized to allow long-term gene therapy and breeds optimism in that, although the host immune system remains a major obstacle, future research may be able to remove this barrier.
